Alfred Altomari - Jan 19, 2022 Form 4 Insider Report for AGILE THERAPEUTICS INC (AGRX)

Role
Chief Executive Officer, Director
Signature
/s/ Al Altomari
Stock symbol
AGRX
Transactions as of
Jan 19, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 08:32 PM
Previous filing
Oct 14, 2021
Next filing
May 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGRX Employee Stock Option (Right to Buy) Award $0 +675K $0.00 675K Jan 19, 2022 Common Stock 675K $0.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 19, 2022. 25% of the shares subject to the stock option vest on January 19, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 19, 2026.